Vanda Pharmaceuticals Inc (VNDA.OQ)

VNDA.OQ on NASDAQ Stock Exchange Global Market

13.32USD
22 Jul 2014
Price Change (% chg)

$0.19 (+1.45%)
Prev Close
$13.13
Open
$13.28
Day's High
$13.60
Day's Low
$13.11
Volume
85,255
Avg. Vol
242,825
52-wk High
$19.25
52-wk Low
$5.74

VNDA.OQ

Chart for VNDA.OQ

About

Vanda Pharmaceuticals Inc. (Vanda) is a biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment of central nervous system disorders. The Company’s product portfolio includes tasimelteon, a compound for the treatment of circadian rhythm sleep disorders (CRSD), which... (more)

Overall

Beta: 1.78
Market Cap (Mil.): $451.20
Shares Outstanding (Mil.): 33.87
Dividend: --
Yield (%): --

Financials

  VNDA.OQ Industry Sector
P/E (TTM): -- 99.85 35.92
EPS (TTM): -1.30 -- --
ROI: -50.51 -0.25 18.26
ROE: -310.33 -1.05 19.14
Search Stocks

UPDATE 2-U.S. FDA approves Vanda's circadian rhythm drug Hetlioz

Jan 31 - Vanda Pharmaceuticals Inc said on Friday that U.S. health regulators have approved its drug Hetlioz to regulate the internal body clocks of blind patients and help normalize sleep patterns.

31 Jan 2014

U.S. FDA approves Vanda's circadian rhythm drug Hetlioz

- Vanda Pharmaceuticals Inc said on Friday that U.S. health regulators have approved its experimental drug to regulate the internal body clocks of blind patients and help normalize sleep patterns.

31 Jan 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: GlobalData
$250.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks